Corporate calendar for Neurocrine Biosciences, Inc. (NBIX): upcoming earnings dates, dividend ex-dates and payment dates, stock splits, shareholder meetings and conference calls. Plan your positions around the key catalysts.
Neurocrine Biosciences, Inc. is a pharmaceutical firm dedicated to the creation, advancement, and commercialization of medicines addressing a spectrum of neurological, endocrine, and psychiatric conditions. Its current therapeutic pipeline and marketed products target disorders such as tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, alongside numerous experimental compounds in various clinical stages.
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|---|---|
| 2026-10-27 | $1.92 | $1.04B |
| 2026-07-30 | $1.65 | $891M |
| 2026-05-05 | $1.22 | $768M |
| 2026-02-11 | $1.80 | $790M |
| 2025-10-28 | $1.58 | $807M |
| 2025-07-30 | $0.98 | $746M |
| 2025-05-05 | $0.54 | $560M |
Price
| Price | $144.21 |
| Market Cap | $14.5B |
| Exchange | NASDAQ |
| Country | US |
Analyst Consensus
| Strong Buy | 0 |
| Buy | 32 |
| Hold | 5 |
| Sell | 0 |
| Strong Sell | 0 |
| Total analysts | 37 |
| Avg rating (1-5) | 0.86 |
Related companies: COO · ELAN · ICLR · RDY · SMMT · SNN
Explore sector: Healthcare · Biotechnology
More sections of NBIX: Overview · Financials · Valuation · Statistics · Estimates · Technical · Ownership · News
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Investment Academy — learn to analyze stocks